Navigation Links
Thyroid cancer -- rising most rapidly among insured patients
Date:7/1/2013

(Lebanon, NH, 6/26/13) The rapid increase in papillary thyroid cancer in the US, may not be linked to increase in occurrence, according to a head and neck surgeon at Dartmouth-Hitchcock Norris Cotton Cancer Center, instead it may be linked to an increase in the diagnosis of pre-cancerous conditions and to a person's insurance status. That is the conclusion of a paper published in Thyroid, a peer reviewed journal of the American Thyroid Association, which included the research of Senior Author Louise Davies, MD, MS, The Veteran's Administration Outcomes Group, White River Junction, Geisel School of Medicine at Dartmouth, and assistant professor of Surgery of The Dartmouth Institute.

"This work shows that access to health care is an important driver in the rising incidence of thyroid cancer," said Davies. "People with insurance are more likely to be diagnosed with thyroid cancer than those without insurance." In addition researchers found that higher education levels and higher rates of white collar employment were also associated with increased diagnosis rates.

Papillary thyroid cancer is rising 8.8 percent in Americans over age 65 who have Medicare. Among adults under age 65, who do not have access to Medicare, the rate of increase is 6.4 percent. The mortality rate from thyroid cancer, however, has not changed.

"We did the study to understand who is at risk of being diagnosed with thyroid cancer, which is now like prostate cancerrecognized to be a disease that is commonly over diagnosed," said Davies.

Over diagnosis is the identification of a cancer that would otherwise not have been identified in a person's lifetime.

"The findings are counterintuitive for many: having good health insurance puts you at risk for something badthe unnecessary identification and treatment of a cancer that was never destined to cause a problem," said Davies.

Davies and lead author Luc Morris, MD, MSc, Memorial Sloan-Kettering Cancer Center, used Surveillance, Epidemiology and End Results (SEER) data to examine papillary thyroid cancer incidence trends in Medicare age and non-Medicare age adults over three decades. They looked at 497 counties in the US over three decades. The Geospatial Shared Resource at Norris Cotton Cancer Center helped the team analyze and map the information.

How will this finding change the practice of medicine? According to Davies, "As a next step we should look to protect patients from unnecessary workups of thyroid findings that do not present a significant threat to their health."


'/>"/>

Contact: Donna Dubuc
Donna.M.Dubuc@Dartmouth.edu
603-653-3615
Dartmouth-Hitchcock Medical Center
Source:Eurekalert

Related medicine news :

1. Animal thyroid extract as effective as T4 in treating hypothyroidism
2. Gene signature test diagnoses benign thyroid growths
3. IPE Kicks Off Phase-2 Clinical Trial for New Hypothyroid Drug
4. Improving voice outcomes after thyroid surgery
5. Drug May Work Against Advanced Thyroid Cancer
6. Thyromine Thyroid Health Supplement Company Now Offers 1 Extra Bottle On Select Packages for Limited Time at HealthCareSupplementz.com
7. Thyroid Disorders Tied to Complications in Pregnancy
8. Underactive Thyroid and Heart Failure a Bad Combination: Study
9. Hypothyroidism Revolution Review and Hypothyroid Diet Plan Revealed by Daily Gossip
10. Byetta Lawsuit News: Woman Alleges Her Thyroid Cancer Is Linked to Byetta Use, Rottenstein Law Group LLP Reports
11. Mild Hyperthyroidism Tied to Higher Death Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... ... Quality metrics are proliferating in cancer care, and are derived from many ... the beholder, according to experts who offered insights and commentary in the current issue ... the full issue, click here . , For the American Society of Clinical ...
(Date:6/26/2016)... , ... June 26, 2016 , ... PawPaws brand ... new product that was developed to enhance the health of felines. The formula is ... The two main herbs in the PawPaws Cat Kidney Support Supplement Soft ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... California (PRWEB) , ... June 25, 2016 , ... "With ... fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... customizable and all within Final Cut Pro X . Simply select a ProHand ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has dedicated ... has implemented orthobiologic procedures as a method for treating his patients. The procedure ... doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016 Research and Markets ... for Companion Diagnostic Tests" report to their offering. ... Companion Diagnostics The World Market for Companion ... medicine diagnostics. Market analysis in the report includes the following: ... (In Vitro Diagnostic Kits) by Region (N. America, EU, ROW), ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
Breaking Medicine Technology: